Tempest Therapeutics, Inc. (TPST)
NASDAQ·Healthcare·Biotechnology
$1.70
-1.17%
Mkt Cap $10.61M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | — | — | — | -$0.62 | -$0.62 | +0.00% | — | — |
| Q4 2025 Nov 5, 2025 | — | — | — | -$3.27 | -$0.79 | +75.84% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$3.23 | -$2.07 | +35.91% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$3.71 | -$3.16 | +14.82% | — | — |
| Q1 2025 Mar 27, 2025 | — | — | — | -$3.12 | -$4.03 | -29.17% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$4.81 | -$5.33 | -10.81% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$6.11 | -$5.46 | +10.64% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$5.72 | -$4.68 | +18.18% | — | — |
| Q1 2024 Mar 19, 2024 | — | — | — | -$4.94 | -$4.42 | +10.53% | — | — |
| Q4 2023 Nov 8, 2023 | — | — | — | -$7.15 | -$6.24 | +12.73% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$7.54 | -$7.02 | +6.90% | — | — |
| Q2 2023 May 10, 2023 | — | — | — | -$8.58 | -$7.15 | +16.67% | — | — |
| Q1 2023 Mar 22, 2023 | — | — | — | -$9.36 | -$8.19 | +12.50% | — | — |
| Q4 2022 Nov 8, 2022 | — | — | — | -$9.88 | -$8.58 | +13.16% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$11.96 | -$10.27 | +14.13% | — | — |
| Q2 2022 May 13, 2022 | — | — | — | -$14.56 | -$15.34 | -5.36% | — | — |
| Q1 2022 Mar 29, 2022 | — | — | — | -$1.23 | -$1.12 | +8.94% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$13.65 | -$15.73 | -15.24% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$11.44 | -$99.22 | -767.31% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$5.25 | -$6.60 | -25.71% | — | — |